Raban V Jeger et al.
Lancet (London, England), 396(10261), 1504-1510 (2020-10-23)
In the treatment of de-novo coronary small vessel disease, drug-coated balloons (DCBs) are non-inferior to drug-eluting stents (DESs) regarding clinical outcome up to 12 months, but data beyond 1 year is sparse. We aimed to test the long-term efficacy and